Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3579]

AACR: Investigational anticancer drug may benefit subgroup of patients with head and neck cancer

AACR: Investigational anticancer drug may benefit subgroup of patients with head and neck cancer

AACR: I-SPY 2 Trial identifies subset of breast cancer patients most likely to benefit from neratinib

AACR: I-SPY 2 Trial identifies subset of breast cancer patients most likely to benefit from neratinib

AACR: New antibody-drug conjugate shows early promise against all forms of melanoma

AACR: New antibody-drug conjugate shows early promise against all forms of melanoma

New blood test approach for quantifying cancer burden

New blood test approach for quantifying cancer burden

AACR: Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

AACR: Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

AACR: First-in-class cancer metabolism drug AG-221 shows clinical activity in advanced blood cancers

AACR: First-in-class cancer metabolism drug AG-221 shows clinical activity in advanced blood cancers

AACR: Study identifies potential predictor of clinical outcome in patients with lung cancer treated with the investigational immunotherapy MK-3475

AACR: Study identifies potential predictor of clinical outcome in patients with lung cancer treated with the...

ELCC: PD-L1 expression and association with survival in mesothelioma

ELCC: PD-L1 expression and association with survival in mesothelioma

ELCC: Immunotherapy data heralds new era of lung cancer treatment

ELCC: Immunotherapy data heralds new era of lung cancer treatment

Certain genetic variants may put bladder cancer patients at increased risk of cancer recurrence

Certain genetic variants may put bladder cancer patients at increased risk of cancer recurrence

More from ecancer